Latest 麻豆女优 Health News Stories
How Pfizer Won the Pandemic, Reaping Outsize Profit and Influence
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success has overshadowed the government鈥檚 covid-fighting strategy.
KHN鈥檚 鈥榃hat the Health?鈥: A World Without 鈥楻oe鈥
The Supreme Court鈥檚 decision overturning Roe v. Wade has created far more questions than it has answered about the continued legality and availability of abortion, as both abortion rights supporters and anti-abortion activists scramble to put their marks on policy. Meanwhile, Congress completes work on its gun bill and the FDA takes up the problem of the next covid-19 booster. Margot Sanger-Katz of The New York Times, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Angela Hart, who reported and wrote the latest KHN-NPR 鈥淏ill of the Month鈥 episode about two identical eye surgeries with very different price tags.
KHN鈥檚 鈥榃hat the Health?鈥: The FDA Goes After Nicotine
The FDA is using its power to regulate tobacco products 鈥 ordering the vaping device Juul off the market and announcing its intention to lower the amount of nicotine in cigarettes and other products. Meanwhile, the Supreme Court rules on Medicare and kidney dialysis, and Congress makes progress on legislation surrounding guns and mental health. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Noam N. Levey about the new KHN-NPR project on the growing impact of medical debt.
Nuevo tratamiento para adelgazar: mucho marketing y resultados discretos
Plenity est谩 aprobado por la FDA como un dispositivo que contiene granos de un hidrogel absorbente de origen vegetal. Cada grano se 鈥渋nfla鈥 hasta 100 veces su tama帽o, llenando una cuarta parte del est贸mago de una persona.
New Weight Loss Treatment Is Marked by Heavy Marketing and Modest Results
Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a person鈥檚 stomach, to help people eat less. Results vary widely but are modest on average.
A Proposal to Import Drugs from Other Countries Creates an Unusual Alliance in the Senate
As a Senate committee considered legislation to reauthorize the FDA鈥檚 user fee program, Sens. Bernie Sanders and Rand Paul agreed on a proposed amendment related to importing drugs from Canada, the U.K., and other nations.
KHN鈥檚 鈥榃hat the Health?鈥: Closing In on Covid Vaccines for 鈥楾he Littles鈥
The wait is nearly over for parents of kids under 5 as a key advisory committee to the FDA recommends authorizing a covid-19 vaccine for the youngest children. Meanwhile, Congress is struggling to fill in the details of its gun control compromise, and, as the Supreme Court prepares to throw the question of abortion legality back to the states, the number of abortions has been rising. Shefali Luthra of The 19th, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Will the US Overcome Its Covid Complacency Even as the Threat Returns?
One million Americans have died from covid-19 鈥 far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nation鈥檚 pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.
KHN鈥檚 鈥榃hat the Health?鈥: Taking a Shot at Gun Control
The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare鈥檚 trustees board.
Misinformation Clouds America鈥檚 Most Popular Emergency Contraception
At a moment when half of U.S. states stand poised to outlaw or sharply curtail abortion services, the nation鈥檚 most popular emergency contraception brand rests in the unlikely stewardship of two private equity firms.
Skirmishes Over Medication Abortion Renews Debate on State vs. Federal Powers
The Biden administration may have authority to allow the use of abortion pills even in states where the practice could be outlawed, say legal experts.
KHN鈥檚 鈥榃hat the Health?鈥: A(nother) Very Sad Week
Two mass shootings in two weeks 鈥 one at a Texas elementary school that killed 19 fourth graders and two teachers 鈥 have reignited the 鈥済uns-as-public-health-problem鈥 debate. But political consensus seems as far away as ever. Meanwhile, the FDA is in the congressional hot seat over its handling of the infant formula shortage. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Richard Baron, head of the American Board of Internal Medicine, about how doctors should discipline colleagues who spread medical misinformation.
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?
High-Tech鈥檚 Business Model Hasn鈥檛 Worked for the Cue Covid Test
Cue got attention with a Super Bowl ad for a stylish high-tech covid-testing machine to use at home. But the product is expensive, which has limited the San Diego company鈥檚 market.
As Red Cross Moves to Pricey Blood Treatment Method, Hospitals Call for More Choice
The nation鈥檚 largest supplier of platelets is moving to a method it says is easier for hospitals, but one that sharply raises costs, leading some centers to demand more options.
Should You Worry About Data From Your Period-Tracking App Being Used Against You?
After a leaked Supreme Court draft opinion was published May 2 suggesting that Roe v. Wade would soon be overturned, social media users started worrying that their use of period-tracking apps could lead to trouble if they sought an abortion and lived in a state with strict limits or bans on the procedure.
KHN鈥檚 鈥榃hat the Health?鈥: The Invisible Pandemic
Covid cases are again climbing, but you wouldn鈥檛 know it from the behavior of public health and elected officials, much less the general public, all of whom seem to want to put the pandemic in the rearview mirror. Meanwhile, the fallout over the leaked Supreme Court draft opinion on abortion continues even as the Senate fails 鈥 again 鈥 to muster the votes to write abortion rights into law. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Alice Miranda Ollstein of Politico, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.
KHN鈥檚 鈥榃hat the Health?鈥: Leaked Abortion Opinion Rocks Washington鈥檚 World
The unprecedented early leak of a Supreme Court draft opinion that would overturn the landmark abortion-rights ruling Roe v. Wade has heated the national abortion debate to boiling. Meanwhile, the FDA, after years of consideration, moves to ban menthol flavors in cigarettes and cigars. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Shefali Luthra of the 19th, and Jessie Hellmann of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN鈥檚 Paula Andalo, who wrote the latest KHN-NPR 鈥淏ill of the Month鈥 episode about a family whose medical debt drove them to seek care south of the border.
Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the Lab
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
KHN鈥檚 鈥榃hat the Health?鈥: News You Might Have Missed
Congress is in recess, so the slower-than-average news week gives us a chance to catch up on underreported topics, like Medicare鈥檚 coverage decision for the controversial Alzheimer鈥檚 disease drug Aduhelm and ominous new statistics on drug overdose deaths and sexually transmitted diseases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
